Gyuris Jeno 4
4 · AVEO PHARMACEUTICALS INC · Filed Jan 28, 2013
Insider Transaction Report
Form 4
Gyuris Jeno
SVP, Head of Research
Transactions
- Award
Common Stock
2013-01-24+32,500→ 112,012 total - Award
Stock Option (right-to-buy)
2013-01-24+32,500→ 32,500 totalExercise: $7.72Exp: 2023-01-24→ Common Stock (32,500 underlying) - Sale
Common Stock
2013-01-28$7.77/sh−767$5,960→ 111,245 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2011, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
- [F2]This option vests in equal monthly installments from January 1, 2013 through January 1, 2017.